Title: Prevalence, Risk Factors, and Treatment Strategies of Polycystic Ovary Syndrome at Various Hospitals, Palakkad: A Prospective Study
Author(s) - Renatt .C. Francis*1, C. I. Sajeeth2, Mini N.M.3
DOI: - 10.23958/ijirms/vol02-i06/02
Aim and Objectives: To monitor and assess the prevalence, risk factors, and treatment strategies of polycystic ovary syndrome.
Materials and Methods: A prospective study was conducted in various hospitals of Palakkad from November 2016- April 2017. A total of 207 cases were collected. Patients of age between 15-50years with polycystic ovary syndrome were included in the study.
Results and Discussion: The maximum number of patients belongs to 21-25 years. Risk factors of study population include hypothyroidism (69%), followed by cardiovascular disease, obesity, migraine etc. Medroxy progesterone (30%), Clomiphene citrate (23%), Ethinyl estradiol (16%), Metformin (15%) etc are given as treatment for PCOS.
Conclusion: From the study it shows that the prevalent age group is 21-25 years. Hypothyroidism is the major risk factor for PCOS. Current treatment strategies include medroxy progesterone, clomiphene citrate, followed by ethinyl estradiol and metformin.
Keywords: PCOS, Risk factors, Prevalence, Treatment strategies
How to Cite this Article?
"Renatt .C. Francis, C. I. Sajeeth, Mini N.M." ‘‘Prevalence, Risk Factors, and Treatment Strategies of Polycystic Ovary Syndrome at Various Hospitals, Palakkad: A Prospective Study" International Journal of Innovative Research in Medical Science(IJIRMS), http://ijirms.in/index.php, Volume 2 Issue 6, June 2017, p. No. 776-778